Global Custom Market Research Reports Provider Company

phone

Nivalis Therapeutics Inc (NVLS) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Nivalis Therapeutics Inc (Nivalis Therapeutics), formerly N30 Pharmaceuticals is a pharmaceutical company that develops a novel class of disease modifying therapies, which can preserve intracellular GSNO in the pathophysiology of cystic fibrosis. The company carries out the discovery, development and commercialization of s-nitrosothiol drugs. It provides products for the treatment of respiratory and cardiopulmonary diseases such as cystic fibrosis, asthma and chronic obstructive pulmonary disease. Nivalis Therapeutics N91115 targets patients with the F508del mutation, which is the common disease causing mutation in cystic fibrosis. The company has developed small molecule inhibitors of the S-nitrosoglutathione reductase protein that can increase CFTR activity and decrease airway inflammation. Nivalis Therapeutics is headquartered in Boulder, Colorado, the US.

Nivalis Therapeutics Inc Key Recent Developments

May 01,2017: Nivalis Therapeutics Reports First Quarter 2017 Financial Results
Feb 13,2017: Nivalis Therapeutics Reports Fourth Quarter and Full-Year 2016 Financial Results
Jan 16,2017: Nivalis Therapeutics unveils corporate restructuring
Jan 12,2017: Nivalis Therapeutics Announces Corporate Restructuring

This comprehensive SWOT profile of Nivalis Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nivalis Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData


Section 1 - About the Company

Nivalis Therapeutics Inc - Key Information
Nivalis Therapeutics Inc - Overview
Nivalis Therapeutics Inc - Key Employees
Nivalis Therapeutics Inc - Key Employee Biographies
Nivalis Therapeutics Inc - Key Operational Heads
Nivalis Therapeutics Inc - Major Products and Services
Nivalis Therapeutics Inc - History
Nivalis Therapeutics Inc - Company Statement
Nivalis Therapeutics Inc - Locations And Subsidiaries
Nivalis Therapeutics Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Nivalis Therapeutics Inc - Business Description
Nivalis Therapeutics Inc - Corporate Strategy
Nivalis Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Nivalis Therapeutics Inc - Strengths
Nivalis Therapeutics Inc - Weaknesses
Nivalis Therapeutics Inc - Opportunities
Nivalis Therapeutics Inc - Threats
Nivalis Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Nivalis Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Nivalis Therapeutics Inc, Key Information
Nivalis Therapeutics Inc, Key Ratios
Nivalis Therapeutics Inc, Share Data
Nivalis Therapeutics Inc, Major Products and Services
Nivalis Therapeutics Inc, History
Nivalis Therapeutics Inc, Key Employees
Nivalis Therapeutics Inc, Key Employee Biographies
Nivalis Therapeutics Inc, Key Operational Heads
Nivalis Therapeutics Inc, Other Locations
Nivalis Therapeutics Inc, Subsidiaries
Nivalis Therapeutics Inc, Key Manufacturing facilities
Nivalis Therapeutics Inc, Key Competitors
Nivalis Therapeutics Inc, SWOT Analysis
Nivalis Therapeutics Inc, Ratios based on current share price
Nivalis Therapeutics Inc, Annual Ratios
Nivalis Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Nivalis Therapeutics Inc, Performance Chart
Nivalis Therapeutics Inc, Ratio Charts

Nivalis Therapeutics Inc (Nivalis Therapeutics), formerly N30 Pharmaceuticals is a pharmaceutical company that develops a novel class of disease modifying therapies, which can preserve intracellular GSNO in the pathophysiology of

View Report

Nivalis Therapeutics Inc (Nivalis Therapeutics), formerly N30 Pharmaceuticals is a pharmaceutical company that develops a novel class of disease modifying therapies, which can preserve intracellular GSNO in the pathophysiology of

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports